Federal Circuit Upholds Genentech Victory Vs. Chiron

Law360, New York (April 7, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit court has upheld Genentech's legal victory in a $1 billion patent battle with biotechnology rival Chiron.

The federal appeals court agreed with the lower court that Chiron had failed to disclose the subject matter of one of the patents for Herceptin, a humanized antibody useful for the long-term treatment of breast cancer.

In 2002, the U.S. District Court for the Eastern District of California invalidated the patent and ruled that Chiron had no claim to share any...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.